Kardassis Dimitris, Roussou Anastasia, Papakosta Paraskevi, Boulias Konstantinos, Talianidis Iannis, Zannis Vassilis I
Department of Basic Sciences, School of Health Sciences, Faculty of Medicine, University of Crete, PO Box 1393, 71500 Heraklion, Greece.
Biochem J. 2003 Jun 1;372(Pt 2):291-304. doi: 10.1042/BJ20021532.
We have shown previously that the hepatic control region 1 (HCR-1) enhances the activity of the human apolipoprotein C-II (apoC-II) promoter in HepG2 cells via two hormone response elements (HREs) present in the apoC-II promoter. In the present paper, we report that the HCR-1 selectively mediates the transactivation of the apoC-II promoter by chenodeoxycholic acid (CDCA) and 9- cis -retinoic acid. CDCA, which is a natural ligand of farnesoid X receptor alpha (FXRalpha), increases the steady-state apoC-II mRNA levels in HepG2 cells. This increase in transcription requires the binding of retinoid X receptor alpha (RXRalpha)-FXRalpha heterodimers to a novel inverted repeat with one nucleotide spacing (IR-1) present in the HCR-1. This element also binds hepatocyte nuclear factor 4 and apoA-I regulatory protein-1. Transactivation of the HCR-1/apoC-II promoter cluster by RXRalpha-FXRalpha heterodimers in the presence of CDCA was abolished by mutations either in the IR-1 HRE of the HCR-1 or in the thyroid HRE of the proximal apoC-II promoter, which binds RXRalpha-thyroid hormone receptor beta (T3Rbeta) heterodimers. The same mutations also abolished transactivation of the HCR-1/apoC-II promoter cluster by RXRalpha-T3Rbeta heterodimers in the presence of tri-iodothyronine. The findings establish synergism between nuclear receptors bound to specific HREs of the proximal apoC-II promoter and the HCR-1, and suggest that this synergism mediates the induction of the HCR-1/apoC-II promoter cluster by bile acids and retinoids.
我们之前已经表明,肝脏控制区1(HCR-1)通过载脂蛋白C-II(apoC-II)启动子中存在的两个激素反应元件(HREs)增强了HepG2细胞中人载脂蛋白C-II启动子的活性。在本文中,我们报道HCR-1选择性介导鹅去氧胆酸(CDCA)和9-顺式视黄酸对apoC-II启动子的反式激活。CDCA是法尼醇X受体α(FXRα)的天然配体,可增加HepG2细胞中apoC-II mRNA的稳态水平。这种转录增加需要维甲酸X受体α(RXRα)-FXRα异二聚体与HCR-1中存在的具有一个核苷酸间隔的新型反向重复序列(IR-1)结合。该元件还结合肝细胞核因子4和载脂蛋白A-I调节蛋白-1。在存在CDCA的情况下,RXRα-FXRα异二聚体对HCR-1/apoC-II启动子簇的反式激活被HCR-1的IR-1 HRE或近端apoC-II启动子的甲状腺HRE中的突变所消除,后者结合RXRα-甲状腺激素受体β(T3Rβ)异二聚体。相同的突变也消除了在存在三碘甲状腺原氨酸的情况下RXRα-T3Rβ异二聚体对HCR-1/apoC-II启动子簇的反式激活。这些发现确立了与近端apoC-II启动子的特定HRE结合的核受体与HCR-1之间的协同作用,并表明这种协同作用介导了胆汁酸和类维生素A对HCR-1/apoC-II启动子簇的诱导。